Skip to main content

URMC Logo

URMC / Research / Research@URMC
Wilmot Cancer Institute Scientists Receive $2M from NCI

Wilmot Cancer Institute Scientists Receive $2M from NCI

The National Cancer Institute awarded more than $2 million to a team at the Wilmot Cancer Institute to continue their study of a gene network that controls cancer progression, with a focus on pancreatic cancer.

6/25/2014
Nature Gives Shout-Out to Wilmot for Immune Therapy Research

Nature Gives Shout-Out to Wilmot for Immune Therapy Research

One of the big topics in cancer research is immunotherapy and the need for a new generation of drugs that spur the immune system to fight tumors. John Frelinger’s lab was featured in a news article in the journal Nature, for its work on refining interleukin-2.

6/4/2014
Using Cancer’s Fingerprint, UR Researchers Clinch a Diagnosis

Using Cancer’s Fingerprint, UR Researchers Clinch a Diagnosis

Rochester scientists are using a gene test to diagnose a difficult-to-detect form of bone marrow cancer – an example of how academic medical centers are applying new technology in ways that play to their strengths to achieve better patient care.

3/5/2014
Prostate Cancer Danger Zone: More Likely for Older, Black Men

Prostate Cancer Danger Zone: More Likely for Older, Black Men

When prostate cancer is detected through a screening test and no symptoms are present, logic would say the disease is probably insignificant and the patient can avoid aggressive treatment. Yet statistics tell a different story: 1 in 6 of these men will have higher-risk disease, according to a University of Rochester study published in Frontiers in Oncology.

1/28/2014
Hematology Event Draws Wilmot Scientists, New Data

Hematology Event Draws Wilmot Scientists, New Data

Several members of the lymphoma and leukemia teams at the James P. Wilmot Cancer Center are to present research at the 55th annual American Society of Hematology (ASH) meeting, Dec. 7 to 10, which is attended by more than 20,000 clinicians and scientists.

12/5/2013